 This paper provides a comprehensive review of the epidemiological trends and public health implications of diabetes in Sub-Saharan Africa. The study found that type 2 diabetes accounts for over 90% of diabetes cases in the region, with population prevalence ranging from 1% to 12%. Type 1 diabetes prevalence is low, ranging from 4 to 12 per 100,000 people. Gestational diabetes prevalence varies widely, from 0% to 9%. Diabetes is associated with a range of complications, including retinopathy, neuropathy, and microalbuminuria. The study also found that diabetes increases the risk of several important infections in the region, including tuberculosis, pneumonia, and sepsis. Antiviral treatment for HIV increases the risk of obesity and insulin resistance. Five-year mortality proportions for patients with diabetes range from 4% to 57%. The study identified barriers to accessing diagnosis and treatment, including a lack of diagnostic tools and glucose monitoring equipment and high cost of diabetes treatment. The total annual cost of diabetes in the region is estimated at US.03 billion, or US.36 per diabetic patient. Overall, the study highlights the significant burden of diabetes in Sub-Saharan Africa and the need for integrated responses to communicable and non-communicable diseases. This article was authored by Hendrickson or Thompson Rehma W. Hall Victoria, and others. We are article.tv, links in the description below.